Allen, Luke N
Karanja, Sarah
Gichangi, Michael
Bunywera, Cosmas
Rono, Hillary
Macleod, David
Kim, Min Jung
Tlhajoane, Malebogo
Burton, Matthew J.
Ramke, Jacqueline
Bolster, Nigel M.
Bastawrous, Andrew
Funding for this research was provided by:
Wellcome Trust (215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z, 215633/Z/19/Z)
Article History
Received: 12 April 2024
Accepted: 5 August 2024
First Online: 26 August 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Kenya Medical research Institute (KEMRI) and LSHTM ethics committees, and Kenya’s National Commission for Science, Technology & Innovation. Written informed consent was obtained from every participant.
: We confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
: NB is a full-time employee and ‘Head of Product and Services’ at Peek Vision Limited. AB is Founder and CEO of the non-profit Peek Vision Group Foundation which wholly owns the subsidiary company Peek Vision Limited. AB is pro-bono CEO for the Foundation and receives a salary from Peek Vision Ltd. All other authors declare no competing interests.